Takács István Gábor

SZTE  Doktori Értekezések Repozitórium (SZTE Repository of Dissertations)

Ph.D. Thesis Inhibition of carbonhydrate cleaving enzymes in STZ induced diabetes mellitus model  István Gábor Takács  Ph.D. School of Biology Supervisors Dr. Anikó Pósa  Dr. András Szekeres    DEPARTMENT OF MICROBIOLOGY  FACULTY OF SCIENCE AND INFORMATICS  UNIVERSITY OF SZEGED   SZEGED  2018 1 Table of contents  1 Table of contents .......................................................... 1-1 2 Introduction .................................................................. 2-2 3 Aims .............................................................................. 3-3 4 Materials and methods ................................................ 4-4 5 Results .......................................................................... 5-6 5.1 Development of α-amylase inhibition measurement method ............................................................................. 5-6 5.2 Effects of plant extracts to the glycoside-hydrolase enzymes ............................................................................ 5-7 5.3 Antioxidant capacity of the selected plant extracts 5-8 5.4 Mass spectrometric analysis of the selected plant extract 5-8 5.5 Cytotoxic and citoprotective effects of the selected plant extracts .................................................................... 5-9 5.6 Analysis of the extracts in in vivo diabetes mice model 5-10 6 Conclusions ................................................................. 6-11 7 Results summarized in the Ph. D. thesis were published in the following articles ...................................................... 7-15    2 Introduction   The treatment of hyperglycaemia is crucial in the management of metabolic syndromes such as type II diabetes. The α-amylase, and α-glucosidase as digestive enzymes have an essential role in glucose release taking part in dietary polysaccharides hydrolysis. These enzymes have important role in diabetes research, because they are potential targets for antidiabetic drug research. It is a commonly accepted strategy to manage hyperglycaemia by the inhibition of α-amylase and α-glucosidase. The inhibition of these enzymes postpones remarkably the adsorption of glucose along with the postprandial hyperglycaemia. The acarbose is widely applied antidiabetic drug that inhibit pancreatic α-amylase and intestinal α-glucosidase. Although it is very effective, but it has several unpleasant gastrointestinal side effects. This is the reason that there is an increased demand for new molecules possessing less side effects. Several clinical studies, dealing with the postprandial glycaemic investigations, have demonstrated the effectiveness of the food polyphenols in the treatment of high blood glucose levels. The berries are rich in these compounds that wild strawberry, bilberry and blueberry were chosen to study the inhibition assays of glycolytic enzymes and to reduce postprandial hyperglycaemia.  3 Aims  Nowadays, the type II diabetes is the most commonly occurring disorder in civilisation, which could be treat successfully using medicinal herbs. To facilitate the possibility of practical applicability of the medicinal herbs the aims of my PhD thesis were the followings:  1. Preparation of several medicinal herbs extracts containing bioactive components and assay of their in vitro anti-diabetic activities. 2. Development of a novel HPLC method for the measurement of in vitro α-amylase activities.  3. Determine the effects on cells of the selected medicinal plant extracts using cell lines.  4. Mapping the possible bioactive components with mass spectrometric investigations.  5. Testing of the herb extracts in vivo in STZ induced and HFHS diet treated diabetic rats.   4 Materials and methods  1. Sample preparation procedures: a. Selection of plants, aquatic extraction of herbs and lyophilization. b. Tannin precipitation from the plant extracts. 2. Examination of the effect of plant extracts on the glycoside-hydrolase enzymes.  a. Development of HPLC method for the measurement of α-amylase inhibition, synthesis and purification of the substrate.  b. Determination of α-amylase inhibition of the plant extracts using the developed method. c. Determination of α-glycosidase inhibition of the plant extracts with spectrophotometric method. 3. Measurement of the antioxidant capacity of the plant extract.  4. Investigation of the extracts with mass spectrometric technique (MALDI-TOF).  5. Cell based bioactivity assays: a. Cytotoxicity assay on H9c2 cells b. Cytoprotecting assay with RTCA-SP system. 6. In vivo assays: a. Applying of chemically induced diabetes model for the test of extracts. b. Applying of HFHS dietic induced model for the test of extracts.    5 Results  5.1 Development of α-amylase inhibition measurement method  During the method development the 2-chloro-4-nitrophenyl-β-D-maltoheptaoside (CNP-G7) substrate was synthetized, which was purified via preparative chromatographic technique. The purity of the final product was checked with liquid chromatography showing the retention time for CNPG-7 6.7 min and for purity 96.9%. For the comprehensive confirmation of our results mass spectrometric examinations were also carried out in positive ionization mode with MALDI-TOF MS technique. The m/z values of potassium and sodium adducts characteristics for the CNPG-7 appeared in the purified substrate on the spectra without any interfering components.    5.2 Effects of plant extracts to the glycoside-hydrolase enzymes  During the pretreatment the aquatic extraction of plant material was carried out followed by lyophilization. The dried plant samples were dissolved in water and after the centrifugation their effects on both α-amylase and α-glucosidase were determined. After the measurements three plants were selected with the 8.84±2.8 µg/ml, 25±8 µg/ml and 27.27±9 µg/ml IC50 values for wild strawberry, blueberry and blackberry, respectively. The effects of the mixture created from these plants in equal ratio was also tested and the observed IC50 values were 11.2 µg/ml and 15.3 µg/ml in the case of α-glucosidase and α-amylase, respectively.  The enzyme inhibition examinations were also carried out after the precipitation of tannins from the mixture causing only 7.2% and 14.9% loss of the original inhibition values for α-amylase and α-glucosidase, respectively. However, the observed inhibition values remained at high level, thus it could be concluded that the inhibition caused not only from the tannin content.  5.3 Antioxidant capacity of the selected plant extracts  The abilities of the plant metabolites to inhibit the releasing of free radicals and the connected harmful side effects termed as antioxidant capacity. The measurement of antioxidant capacity were carried out in each plant extract. The C-vitamin equivalent antioxidant capacities of blueberry, wild strawberry and blackberry were 809.15±68.27 µg/mg, 490.47±56.97 µg/mg and 366.32±42.67 µg/mg, respectively.  5.4 Mass spectrometric analysis of the selected plant extract  During the measurement of the plant extracts, the metabolites were identified in the samples based on their kationized – protonated, potassium and/or sodium adducts – quasi molecular ions. If all of three molecular ions were detected including m/z values of [M+H]+, [M+K]+ and [M+Na]+ , the chemical composition s were detected with the Metabolomics Workbench Databank. Remarkable part of the detected metabolites is belonging to the group of flavonoids, whose biological activities are known from more aspects.  5.5 Cytotoxic and citoprotective effects of the selected plant extracts  The possible cytotoxic effects of the plant extracts were tested by MTT-assay, while the cytoprotective effects were measured with real-time cell electronic sensing system (RT-CES) using H9c2 embryonal rat heart cell lines. According to the results of the performed examinations, it could be concluded that the applied plant extracts cannot be considered toxic in the used in vitro setup. However, in the cytoprotection experiments the harmful effects of the hydrogen-peroxide as stressor could not be protected via none of the extracts.  5.6 Analysis of the extracts in in vivo diabetes mice model   For the first in vivo model STZ induced CD1mice were used. Five days after the STZ treatment, the blood glucose level was significantly improved due to the starch administration. The effects of both the acarbose and plant extract treated mice were similar, because in both cases the blood glucose concentrations reduced. For further diabetic mice model C57B16 mice were used. This type of mice susceptible to diet induced obesity. The control group for type II diabetes model had the same age and fed with normal diet. This experimental group showed no difference after administration of starch and plant extracts or acarbose. The starting blood glucose level of this group were notably lower compared to the diabetic mice. After administration of starch followed by acarbose or plant extract the blood glucose level remained stable throughout the experiment in both cases.  6 Conclusions  1. Eight plants were selected based on literature whose glycoside-hydrolase activity were teted in vitro. The plant extracts inhibited the α-amylase with dose dependent manner. The related IC50 value of each plants were determined. The strawberry extract showed the lowest value while the IC50 value of blueberry and raspberry were significantly higher.   2. Novel HPLC method was developed for the sensitive analysis of α-amylase. The application of HPLC makes it possible to separate components and analyse their quantity as well as the reaction rate could be calculated. A new synthetic substrate was applied that forms stronger bonds with the active centrum of amylase, consequently it models well the natural environments. The gained β-configuration within the synthesis defend the substrate against the cleavage of amylase, thus the chromophore group remains on the substrate causing the specificity of the detection. The purity of the substrate was determined by liquid chromatography and MALDI-TOF MS.  3. Before the animal experiments to check the effects of the plant extracts on cells in vitro cytotoxic and cytoprotecting tests were applied.  The results showed that none of the examined plant had any cytotoxic effect in the investigated concentrations range.  4. The components of plants were analysed with mass spectrometric methods. Using the MALDI-TOF MS results, the formula of a lot of compound were determined and their potential names were determined according to the literature. Based on the results the extracts contained high amount of polyphenolic substances, from which the most important could be the tannins, ellagic tannins, flavonoids and its derivatives.  5. During in vivo experiments the plant extracts were tested in both diabetic mice models. The chemically induced diabetes model is an easy and cost-effective method for studying the pathogenesis of type I diabetes, thus this method was applied on CD1 mice with STZ induction. To test the model type II diabetes, HFHS diet induced, pre-diabetic obese model was applied. For these experiments, C57BL6 mice were used that are susceptible to the diet induced diabetic conditions. In both models the blood glucose level was examined by tail blood. The results showed that the applied plant extracts effectively attenuate postprandial hyperglycaemia in normal and pre-diabetic as well as STZ induced mice. The utilization of mixture of the extracts of the three plants confirmed the applicability of these plants in the treatment of the postprandial hyperglycaemia by the inhibition of α-amylase and α-glucosidase. Furthermore, it could be used safely, because none of cytotoxic effects were observed. The results of our study suggests, involving the in vitro and in vivo examinations, that the anti-hyperglycaemic effect of the plant extracts are in correlation with the inhibition of α-amylase and α-glucosidase. The extracts are not toxic and there are no obvious side-effects, consequently it can be aimed as complementer treatment of type II diabetes or metabolic syndrome.              7 Results summarized in the Ph. D. thesis were published in the following articles  MTMT identifier: 10057721  Publications in referred journals HPLC method for measurement of human salivary α-amylase inhibition by aqueous plant extracts. Takács, I., Takács, Á., Pósa, A., Gyémánt, Gy. Acta Biologica Hungarica,  2017; 68(2):127-136. doi: 10.1556/018.68.2017.2.1; Q3; IF 0.581 Simple ITC method for activity and inhibition studies on human salivary α-amylase Lehoczki, G., Szabó, K., Takács, I., Kandra, L., Gyémánt, Gy. Journal of Enzyme Inhibition and Medicinal Chemistry, 2016; 31,(6):1648-1653., Q2 IF: 4.293   Conference abstracts summarizing the results of the Ph. D. thesis  Investigation of α-amylase inhibitory activities of herbal extracts with a HPLC-based assay  Takács, I., Gyémánt, Gy., Boros, K., Hohmann, J., Csupor, D. Planta Medica, 2015; 81(16) 1520 DOI: 10.1055/s-0035-1565726  Anti-Amylase and antifungal effect of common herbs and spices Lehoczki, G., Kovács, R., Takács, I., Pető, K., Gyémánt, Gy. 8th Central European Conference “Chemistry towards Biology“ 28th August – 1st September 2016 Brno, Czech Republic Published by University of Veterinary and Pharmaceutical Sciences Brno, Czech Republic  ISBN 978-80-7305-777-0 Új HPLC eljárás az alfa-amiláz aktivitás és gátlás mérésére  Takács, I., Pósa, A., Szekeres, A., Endre, G., Gyémán, Gy. 23rd International Symposium on Analytical and Environmental Problems October 9-10, 2017 University of Szeged, Department of Inorganic and Analytical Chemistry Szeged Hungary                

Szénhidrátbontó enzimek gátlásának vizsgálata STZ indukált diabetes mellitus egérmodellben

http://doktori.bibl.u-szeged.hu/9724/3/THESIS%20final%20Tak%C3%A1cs%20Istv%C3%A1n%20%202018..pdf

Szénhidrátbontó enzimek gátlásának vizsgálata STZ indukált diabetes mellitus egérmodellben

Abstract

Similar works

Full text

Available Versions

SZTE Doktori Értekezések Repozitórium (SZTE Repository of Dissertations)